AACR Annual Meeting 2023: Therapy Advances for Patients With Rare Melanoma Types
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
Progress Against Cancer
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment...
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.